{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-22-019515","form_type":"8-K","ticker":"SNDX","cik":"0001395937","company_name":"Syndax Pharmaceuticals Inc","filed_at":"2022-05-11T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.463920+00:00","generated_at":"2026-06-25T20:40:39.808708+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Syndax stockholders elect directors, approve say-on-pay, ratify auditor at 2022 annual meeting","bullets":["All three director nominees elected: Katkin 27.7M for/16.4M withheld, Morrison 25.4M/18.7M, Podlesak 23.4M/20.7M.","Advisory vote on executive compensation approved: 43.9M for, 227K against, 7.8K abstain.","Stockholders recommended annual say-on-pay frequency (43.4M for 1 year); board adopted annual vote.","Ratification of Deloitte & Touche as auditor: 49.2M for, 17K against, 759 abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-22-019515","json":"https://secwatch.observer/filing/0001564590-22-019515.json","markdown":"https://secwatch.observer/filing/0001564590-22-019515.md","text":"https://secwatch.observer/filing/0001564590-22-019515.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1395937/000156459022019515/0001564590-22-019515-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1395937/000156459022019515/sndx-8k_20220511.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T20:40:39.808708+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}